Search Results - Marco C. Post
- Showing 1 - 14 results of 14
-
1
Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis by Vivan J. M. Baggen, Tim Leiner, Marco C. Post, Arie P.J. van Dijk, Jolien W. Roos‐Hesselink, Eric Boersma, Jesse Habets, Gertjan T. Sieswerda
Published 2016Revisão -
2
-
3
Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis by Marloes P. Huitema, Schmid María Marcela, Veronique M.M. Vorselaars, Sanne Boerman, Repke J. Snijder, Hendrik W. van Es, Herre J. Reesink, Jan C. Grutters, Marco C. Post
Published 2015Carta -
4
Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material by Joey M. Kuijpers, David R. Koolbergen, Maarten Groenink, Kathinka C Peels, Constant L.A. Reichert, Marco C. Post, Hans A. Bosker, Elly M.C.J. Wajon, Aeilko H. Zwinderman, Barbara J.M. Mulder, Berto J. Bouma
Published 2016Artigo -
5
Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography by M. M. P. Driessen, Marjolijn A. Schings, Gertjan T. Sieswerda, Pieter A. Doevendans, Erik H.J. Hulzebos, Marco C. Post, Repke J. Snijder, Jos J.M. Westenberg, Arie P.J. van Dijk, Folkert J. Meijboom, Tim Leiner
Published 2018Artigo -
6
The evolution of survival of pulmonary arterial hypertension over 15 years by Paul M. Hendriks, Diederik P. Staal, Liza D. van de Groep, Leon M. van den Toorn, Prewesh P. Chandoesing, Robert M. Kauling, Hans‐Jurgen Mager, Annemien E. van den Bosch, Marco C. Post, Karin A. Boomars
Published 2022Artigo -
7
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension by Laurent Savale, Marloes P. Huitema, Oksana A. Shlobin, Vasileios Kouranos, Steven D. Nathan, Helena Peres Peres Nunes, Rohit Gupta, Jan C. Grutters, Daniel A. Culver, Marco C. Post, Daniel R. Ouellette, Elyse E. Lower, Tamara Al-Hakim, Athol U. Wells, Marc Humbert, Robert P. Baughman
Published 2022Revisão -
8
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification by Annelieke C.M.J. van Riel, Mark J. Schuuring, Irene D. van Hessen, A.H. Zwinderman, Luc Cozijnsen, Constant L.A. Reichert, Jan C.A. Hoorntje, Lodewijk J. Wagenaar, Marco C. Post, Arie P.J. van Dijk, Elke S. Hoendermis, Barbara J.M. Mulder, Berto J. Bouma
Published 2014Artigo -
9
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricu... by Iréne Lang, Arne K. Andreassen, Asger Andersen, Hélène Bouvaist, Gerry Coghlan, Pilar Escribano Subías, Pavel Jansa, Grzegorz Kopeć, Marcin Kurzyna, Hiromi Matsubara, Bernhard C. Meyer, Massimiliano Palazzini, Marco C. Post, Piotr Pruszczyk, Lorenz Räber, Marek Roik, Stephan Rosenkranz, Christoph B. Wiedenroth, Carlo Redlin-Werle, Philippe Brénot
Published 2023Artigo -
10
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) by Omer Eker, Edoardo Boccardi, Ulrich Sure, Maneesh C. Patel, Saverio Alicante, Ali Alsafi, Nicole Coote, Freya Droege, Olivier Dupuis, Annette Dam Fialla, Bryony A. Jones, Ujwal Kariholu, Anette Drøhse Kjeldsen, David Lefroy, Gennaro M. Lenato, Hans Jurgen Mager, Guido Manfredi, Troels Halfeld Nielsen, Fabio Pagella, Marco C. Post, Catherine Rennie, Carlo Sabbà, Patrizia Suppressa, Pernille Mathiesen Toerring, Sara Ugolini, Elisabetta Buscarini, Sophie Dupuis‐Girod, Claire L. Shovlin
Published 2020Artigo -
11
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)? by Sophie Dupuis‐Girod, Claire L. Shovlin, Anette Drøhse Kjeldsen, Hans‐Jurgen Mager, Carlo Sabbà, Freya Droege, Anne‐Emmanuelle Fargeton, Annette Dam Fialla, S. Gandolfi, Ruben Hermann, Gennaro M. Lenato, Guido Manfredi, Marco C. Post, Catherine Rennie, Patrizia Suppressa, Ulrich Sure, Elisabetta Buscarini, Claudia Crocione, Ria Blom, Luisa M. Botella, Fernando Brocca, Caroline Coxall, Karen T. Druckman, Didier Erasme, Paolo Roberto Federici, Christina Grabowski, Mildred Lundgren, Tone Søderman, Dara Woods
Published 2022Artigo -
12
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure by Barry A. Borlaug, J. Anthony Blair, Martin Bergmann, Heiko Bugger, Daniel Burkhoff, Leonhard Bruch, David S. Celermajer, Brian Claggett, John G.F. Cleland, Donald E. Cutlip, Ira Dauber, Jean‐Christophe Eicher, Qi Gao, Thomas M. Gorter, Finn Gustafsson, Chris Hayward, Jan Van der Heyden, Gerd Hasenfuß, Scott L. Hummel, David M. Kaye, Jan Komtebedde, Joseph M. Massaro, Jeremy A. Mazurek, S. McKenzie, Shamir R. Mehta, Mark C. Petrie, Marco C. Post, Ajith Nair, Andreas Rieth, Frank E. Silvestry, Scott D. Solomon, Jean‐Noël Trochu, Dirk J. van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah
Published 2022Artigo -
13
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial by Pascal R.D. Clephas, Victor W Zwartkruis, Jishnu Malgie, Marco W.F. van Gent, Hans‐Peter Brunner‐La Rocca, Mariusz K. Szymanski, Vokko P. van Halm, M. Louis Handoko, Wouter E.M. Kok, Folkert W. Asselbergs, Roland R.J. van Kimmenade, Olivier C. Manintveld, Nicolas M D A van Mieghem, Saskia L.M.A. Beeres, Marco C. Post, C. Jan Willem Borleffs, Raymond Tukkie, Arend Mosterd, Gerard C.M. Linssen, Ruud F. Spee, Mireille E. Emans, Tom D.J. Smilde, Jan van Ramshorst, C Kirchhof, Margriet W Feenema-Aardema, Carlos A. da Fonseca, Mieke van den Heuvel, Ronald Hazeleger, Martijn van Eck, Loek van Heerebeek, Eric Boersma, Michiel Rienstra, Rudolf A. de Boer, Jasper J. Brugts
Published 2024Artigo -
14
Contemporary g<scp>uideline‐directed</scp> medical therapy in de novo, chronic, and worsening heart failure patients: First data from the <scp>TITRATE‐HF</scp> study by Jishnu Malgie, Mariëlle I. Wilde, Pascal R.D. Clephas, Mireille E. Emans, Stefan Koudstaal, Jeroen Schaap, Arend Mosterd, Jan van Ramshorst, Alexander J. Wardeh, Sandra van Wijk, Mieke van den Heuvel, Eric Wierda, C. Jan Willem Borleffs, Colette E Saraber, Saskia L.M.A. Beeres, Roland van Kimmenade, Wouter Jansen Klomp, Robert N. Denham, Carlos A. da Fonseca, IJsbrand T. Klip, Olivier C. Manintveld, Robert M.A. van der Boon, Clara E.E. van Ofwegen, A. Egemai Yilmaz, Ron Pisters, Gerard C.M. Linssen, Nikola Faber, Loek van Heerebeek, J. E. C. van de Swaluw, L. J. Bouhuijzen, Marco C. Post, Aaf F.M. Kuijper, K. W. Wu, Eugène A. van Beek, Tim Hesselink, Lennaert Kleijn, Maurice J Kurvers, René A. Tio, Jorina Langerveld, Bas M. van Dalen, J.W.M. van Eck, M. Louis Handoko, Walter Hermans, Hetty J. J. Koornstra-Wortel, Mariusz K. Szymanski, Dennis Rooker, Kenneth Tandjung, Sabine Eijsbouts, Folkert W. Asselbergs, Peter van der Meer, Hans‐Peter Brunner‐La Rocca, Rudolf A. de Boer, Jasper J. Brugts
Published 2024Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cardiology
Pulmonary hypertension
Ejection fraction
Heart failure
Cohort
Heart disease
Pathology
Pediatrics
Pulmonary artery
Radiology
Sarcoidosis
Surgery
Atrial fibrillation
Blood pressure
Cardiac magnetic resonance imaging
Cohort study
Confidence interval
Environmental health
Hazard ratio
Intensive care medicine
Interquartile range
Magnetic resonance imaging
Population
Proportional hazards model
Telangiectasia
Angina
Angiology
Angioplasty